Equivariant 3D-Conditional Diffusion Model for de Novo Drug Design

Jia Zheng, Hai Cheng Yi, Zhu Hong You

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

De novo drug design speeds up drug discovery, mitigating its time and cost burdens with advanced computational methods. Previous work either insufficiently utilized the 3D geometric structure of the target proteins, or generated ligands in an order that was inconsistent with real physics. Here we propose an equivariant 3D-conditional diffusion model, named DiffFBDD, for generating new pharmaceutical compounds based on 3D geometric information of specific target protein pockets. DiffFBDD overcomes the underutilization of geometric information by integrating full atomic information of pockets to backbone atoms using an equivariant graph neural network. Moreover, we develop a diffusion approach to generate drugs by generating ligand fragments for specific protein pockets, which requires fewer computational resources and less generation time (65.98% ∼ 96.10% lower). DiffFBDD offers better performance than state-of-the-art models in generating ligands with strong binding affinity to specific protein pockets, while maintaining high validity, uniqueness, and novelty, with clear potential for exploring the drug-like chemical space.

Original languageEnglish
Pages (from-to)1805-1816
Number of pages12
JournalIEEE Journal of Biomedical and Health Informatics
Volume29
Issue number3
DOIs
StatePublished - 2025

Keywords

  • Drug discovery
  • artificial intelligence
  • equivariant diffusion model
  • fragment-based drug design
  • molecular generation

Fingerprint

Dive into the research topics of 'Equivariant 3D-Conditional Diffusion Model for de Novo Drug Design'. Together they form a unique fingerprint.

Cite this